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Background: In 2009 Lesotho had an estimated TB prevalence of 696 cases/100 000 
population − the 4th highest in the world. This epidemic was characterised by high rates 
of death, treatment failure and unknown treatment outcomes. These adverse outcomes 
were attributable to a high rate of TB and/or HIV co-infection and weaknesses in the 
implementation of Lesotho’s National Tuberculosis Programme (NTP). This study was 
conducted in St Joseph’s Hospital, Roma (SJHR) to assess the implementation of the NTP.
Method: Records of 993 patients entered into the SJHR TB register between 2007 and 2008 
were reviewed. Patients’ treatment details were extracted from the register, validated and 
analysed by STATA 10.0.
Results: Of 993 patients registered: 88% were new patients, 37% were diagnosed on sputum 
smear microscopy alone, 35% were diagnosed on sputum smear microscopy with chest 
X-ray, whilst 25% were diagnosed on chest X-ray alone. In addition: 33% were sputum 
smear positive, 45% were sputum smear negative, and 22% had extra-pulmonary TB. As 
to treatment outcome: 26% were cured, 51% completed treatment, and 51% converted 
from sputum smear positive to sputum smear negative over six months, whilst 16% died. 
Regarding HIV, 77% of patients were tested for HIV and 59% had TB and/or HIV co-
infection. Of ten NTP targets only the defaulter and treatment failure rate targets were met.
Conclusion: Whilst only two out of ten NTP targets were met at SJHR in 2007–2008, 
improvements in TB case management were noted in 2008 which were probably due to the 
positive effects of audit on staff performance.
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Exécution du programme national du Lesotho contre la Tuberculose à l’Hôpital St Joseph 
de Roma, en 2007 et 2008.
Historique: En 2009 le Lesotho avait une fréquence estimée de Tuberculose de 696 cas pour 
100 000 habitants − la 4ème la plus élevée du monde. Cette épidémie était caractérisée par 
un taux élevé de décès, l’échec des traitements et les résultats des traitements inconnus. Ces 
résultats négatifs étaient attribués au taux élevé de Tuberculose et/ou à une coïnfection VIH, 
ainsi qu’à des lacunes dans la mise en œuvre du Programme national du Lesotho contre la 
Tuberculose (NTP). Cette étude a été réalisée à l’HôpitaL St Joseph de Roma (SJHR) pour 
évaluer la mise en œuvre du NTP.
Méthode: Les dossiers des 993 patients inscrits  dans le Registre de Tuberculose de l’hôpital 
St Joseph entre 2007 et 2008 ont été révisés. Les informations sur le traitement des patients ont 
été tirées du registre, validées et analysées par STATA 10.0.
Résultats: sur les 993 patients enregistrés: 88% étaient de nouveaux patients, 37% avaient été 
diagnostiqués simplement par examen microscopique des expectorations, 35% avaient été 
diagnostiqués par examen microscopique des expectorations et une radiographie pulmonaire, 
alors que 25% avaient été diagnostiqués simplement sur radiographie pulmonaire. En outre: 
33% des cas avaient un frottis d’expectoration positif, 45%  un frottis d’expectoration négatif 
et  22% avaient une Tuberculose extra-pulmonaire. Quand aux résultats des traitements: 26% 
des cas étaient guéris, 51% avaient terminé le traitement, et 51% étaient passés du prélèvement 
d’expectorations positif à un prélèvement négatif en l’espace de 6 mois, alors que 16% étaient 
décédés.  En ce qui concerne le VIH, 77% des malades avaient le VIH et 59% avaient à la fois 
la Tuberculose et le VIH. Sur les dix objectifs du NTP seuls les objectifs du taux des abandons 
et du taux d’échec au traitement ont été atteints.
Conclusion: Bien que seulement deux objectifs sur dix du programme NTP aient été réalisés 
au SJHR de 2007 à 2008, on a remarqué des améliorations en 2008 dans la gestion des cas de 
Tuberculose, ce qui est
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 Introduction
Worldwide there were an estimated 9.2 million new cases 
of tuberculosis (TB) in 2006 of which 4.1 million were TB 
sputum smear-positive. This TB epidemic is perpetuated 
by the transmission of the TB bacillus from sputum smear-
positive patients to uninfected individuals and will be halted 
only when 70% of TB smear-positive patients are detected 
and 85% of those are cured.1,2
The member states of the United Nations are determined to 
halt this epidemic by the application of the World Health 
Organization (WHO) TB programme through the 12 WHO 
Regions.3 This resolve was also evident in 2000 when the 
United Nations Millennium Declaration was adopted 
by the 189 member states and detailed eight Millennium 
Development Goals (MDG). The 6th goal, namely to combat 
HIV and/or AIDS, malaria and other diseases, included the 
target to reduce the incidence, prevalence and death rates 
associated with tuberculosis and to increase the proportion 
of tuberculosis cases detected and cured under Directly 
Observed Treatment Short Course (DOTS).4
This universal drive was augmented in 2000 by the Stop 
TB Partnership, which called for action from ministerial 
delegations from 20 countries with the highest burden of 
TB. In addition in 2006 the Global Plan to Stop Tuberculosis 
was launched with the aim of treating 50 million people for 
TB and enrolling 3 million patients who have both TB and 
HIV onto antiretroviral therapy (ARV) by 2015. The Plan 
aims to halve TB prevalence and deaths by 2015 compared 
with 1990 levels.
National Tuberculosis control programmes
These initiatives are available to assist states to formulate 
effective National Tuberculosis Programmes (NTPs). States 
will succeed with their NTPs to the extent that they can 
find the political will to fund, resource, and drive their 
NTPs through health care structures capable of effectively 
delivering TB services. Many of those states that are worst 
affected by TB lack health care infrastructures capable of 
delivering TB treatment to infected individuals.5
An NTP should be able to detect at least 70% of smear 
positive pulmonary TB patients and successfully treat or cure 
85% of such cases and maintain this level of performance 
indefinitely. To achieve these goals of high TB case detection 
and an increased cure rate an NTP must have a permanent 
presence nationwide and be capable of delivering 
inexpensive and simplified technologies through its health 
services. Such NTPs are generally run by a manager based in 
a central TB unit who is responsible to the minister of health.6
The credibility of an NTP is judged by the programme’s 
ability to supply antituberculous drugs to TB patients when 
they need them – such services are usually provided free. An 
effective NTP can strengthen a weak health care system in 
a developing country. Surveillance and standardisation of 
data recording, collecting and reporting are necessary for 
successful TB control.7,8,9
Conditions necessary for a successful National 
Tuberculosis Programme
Modern TB treatment hinges on the detection of sputum 
positive patients, the application of standard treatment 
protocols and the recording of patient data in records that 
allow for analysis and comparison of results between 
different settings. TB case management has been simplified 
and standardised so that generalists can be trained to 
diagnose and treat the disease.
TB treatment succeeds where patients complete their 
treatment, have exit sputa examined, have an accurate 
account of their treatment recorded in a standard TB register, 
have drugs available and where DOTS is in place. Treatment 
succeeds too where TB staff are familiar with TB treatment 
protocols and where the TB care delivered is patient-centred. 
Since it was introduced in 1994, DOTS has become a key 
underpinning element in all successful TB programmes. 
Since 1994 the global treatment success rate has been high 
with 8 out of 22 high-burden countries reaching the 85% 
target rate.
In the four WHO Regions, including the African Region, 
where TB targets were not met their failure to meet NTP 
targets were explained by high death rates, treatment failure, 
and unknown outcomes through default, transfer without 
follow-up or evaluation. All of these reasons apply in 
Lesotho. The high HIV infection rate in these countries may 
explain the high TB death rate seen.
TB services are generally delivered through secondary 
hospitals in sub-Saharan African (SSA) countries such as 
Lesotho. TB services need staff who are familiar with WHO 
TB protocols – these may need adaptation to a particular 
country’s NTP. To ensure that patients comply with TB 
treatment, staff should relate well to patients and should 
behave in a patient-centred way. To succeed, an NTP should 
be fully incorporated into the running of a hospital. Many 
hospitals in high-burden countries are resource-constrained 
and obliged to provide TB services to patients from large 
catchment areas.
Tuberculosis in Lesotho
The Lesotho Department of Health fully subscribes to the 
WHO TB programme, the MDGs and the Stop TB Partnership 
target of halving the prevalence and mortality due to TB by 
2015, as compared with the 1990 levels. To achieve these 
goals, Lesotho’s NTP will need to be strengthened and allied 
with the country’s HIV and/or AIDS programme – this will 
require a high level of political commitment to the NTP from 
the government.
In 2009 the WHO Global TB Report9 listed Lesotho, as 
having the fourth highest estimated TB prevalence in the 
world (696 cases/100 000 population). Lesotho has a high 
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TB prevalence associated with a high rate of HIV infection. 
The TB infection rate is rising in SSA countries in contrast 
with countries in Europe where the TB epidemic has been 
contained. Lesotho’s high TB-HIV burden and the difficulties 
that Lesotho’s health care system experiences are reflected 
in the poor results it has had in dealing with Lesotho’s TB 
epidemic and meeting TB treatment targets.
St Joseph’s Hospital, Roma
St Joseph’s Hospital (SJHR) is a 120-bedded district hospital 
located in Roma, a semi-rural area with a population of 14 000; 
which is 45 km south of Maseru, the capital of the Kingdom 
of Lesotho. District hospitals in Lesotho have failed to reach 
the TB and HIV treatment targets set for them by the national 
department of health. These hospitals have found it difficult 
to combine the clinical care of patients with the application 
of standard TB treatment protocols. The present study was 
undertaken in SJHR to determine how well the Lesotho NTP 
was being applied there and to identify areas of weakness 
and to make recommendations for their rectification.
Methods
This retrospective cohort study was conducted on 993 patients 
entered into the SJHR TB register for the years 2007 and 2008. 
The records of seven patients whose records were incomplete 
or who were started on treatment and then transferred to 
another facility outside the SJHR catchment area were excluded 
from the study. A total of 993 patients were therefore included 
in the study. A baseline evaluation was made, patient records 
were checked after 2–3 months’ intensive treatment, and after 
6 months’ treatment outcome measurements were made.
TB treatment data was extracted from the TB register for all 
patients treated at SJHR from 01 January 2007 to 31 December 
2008. This register, which was a version adapted from 
the WHO model, was issued to SJHR by the NTP. The TB 
patient data was extracted, checked for accuracy, assigned a 
numerical code to ensure patient anonymity, and entered onto 
an Excel spreadsheet before analysis by STATA 10.0. Patient 
confidentiality was maintained by limiting staff access to 
patient’s datasets to the researcher and two assistants. Data 
checks were performed on all categorical and continuous 
variables captured for values that were not within plausible 
range, and cross-checking of variables was also done. Analysis 
included descriptive statistics, comparison of continuous 
measurements with a t-test and categorical measurement 
with a chi-square test. Nine hundred and ninety three (993) 
patients’ records were analysed in 2007 and 2008. Statistical 
significance level was set at 0.05. TB indicators achieved by 
St Joseph’s hospital were compared with the national targets 
set by the Lesotho national TB programme.
Results
Demographic and clinical characteristics of the 
study population
The demographic and clinical characteristics of the study 
population are shown in Table 1.
Findings of note were that there was no difference in the 
median age of presentation of TB patients in 2007 and 2008 
and that more males attended the TB programme. There was 
a decrease in sputum bacteriological coverage of patients 
from 77.2% recorded in 2007 to 65.2% by the end of 2008. 
The mode of TB presentation showed significant reduction 
in smear negative PTB (from 59.1% recorded in 2007 to 30.4% 
by the end of 2008), but an increase in the detection of smear 
positive patients from 28.9% in 2007 to 36.7% by the end of 
2008. There was a significant increase in extra-pulmonary 
TB from 12.0%, to 32.9% by the end of 2008. There was no 
change in the pattern of TB presentation in the patients 
between 2007 and 2008. New TB cases treated in 2007 were 
87.6% and 2008 were 88.7%. Sputum conversion showed a 
marginal increase from 48.8% in 2007 to 53.1% by the end 
of 2008. Treatment outcome showed a marginal increase in 
cure rate and treatment success by the end of 2008. There 
was also a marginal decrease in mortality, treatment failure, 
defaulters and transferred outcome by the end of 2008. 
Overall, treatment outcome by the end of 2008 showed 
improved outcome. HIV collaborative activities showed 
improved outcome in HIV testing amongst TB patients, 
cotrimoxazole and antiretroviral uptake amongst TB and/or 
HIV co-infected patients. There was a decrease in the mean 
CD4 counts of patients who presented in 2008 (155 cells/Ul) 
when compared to 2007 (173 cells/Ul).
Comparison of outcome indicators with national 
TB targets
The comparison of targets achieved by St Joseph’s TB 
programme with the national target set by the Lesotho NTP 
for 2007 and 2008 are shown in Table 2.
Findings of note were that there was an increase in 
detection of pulmonary smear positive TB from the baseline 
value of 28.9% (2007) to 36.7% reported in 2008, though still 
less than the national target of 50%. An increase from the 
baseline value of sputum conversion (new smear positive 
pulmonary TB) from 48.8% to 53.1% was noticed (national 
target is > 85%). There was an improvement of about 20% in 
cure rate by the end of 2008 (from 10.9% in 2007 to 29.9% in 
2008), though this was still far below the national target of 
85%. However, treatment success increased from (74.2% in 
2007 to 76.8%) in 2008, 8.2% less than the national target of 
85%. There was no significant fluctuations in the defaulter 
rate between 2007 and 2008, defaulter rates was less than 
1% in both years, 0.6% and 0.8% (national target < 5%). 
There was a 2% reduction in mortality by the end of 2008 
from 17.2% in 2007 and 15% in 2008 (national target [< 5%]).
In terms of TB and/or HIV collaboration activities, the 
proportion of TB patients offered HIV counselling and 
testing increased from 69.9% in 2007 to 84.7% in 2008 and 
the proportion of HIV positive TB patients started on 
cotrimoxazole increased by 7% from 60.3% in 2007 to 67.5% 
in 2008. An increase of about 60% was seen in the proportion 
of HIV positive patients eligible for HAART and commenced 
on it by the end of 2008. In 2007 30.2% of those eligible 
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for HAART were commenced, and by the end 2008 it had 
increased to 93.3%. In summary then, of ten TB programme 
indicators examined in 2007 and 2008 two were met, the 
defaulter and treatment failure rates.
Discussion
This retrospective cohort study, which essentially amounted 
to a clinical audit, was undertaken in order to determine 
where improvements could be made in the delivery of TB 
and HIV care at SJHR.
Case detection, sputum conversion and 
treatment outcome
The proportion of patients diagnosed as having TB by means 
of sputum smear microscopy increased from 29% in 2007 to 
37% in 2008, as did the proportion of patients diagnosed by 
sputum microscopy and chest x-ray (CXR), although these 
rates still fell far short of the NTP and STOP TB target of 70%.
The low sputum conversion rate (51%) can be attributed to 
the fact that 30% of patients were started on the secondary 
phase of TB treatment after an initial 2 months of intensive 
treatment on the basis of chest x-ray findings alone without 
sputum examination. In addition 10% of sputum results were 
not available for evaluation after 2 months and consequently 
could not be reported either as sputum converted (negative) 
or as treatment failure (sputum positive). A small but 
gratifying reduction in deaths was noted from 17% in 2007 
to 15% in 2008.
Whilst at 25% the cure rate is far below the requisite 85% 
this rate did improve from 20% in 2007 to 30% in 2008. The 
low cure rate is attributable to the low sputum conversion 
rate during the intensive treatment phase and the high 
treatment completed rate of 54% without bacteriological 
confirmation. The high treatment completed rate is reflective 
of the fact that nearly 60% of the patients attending had TB/
HIV co-infection and were either sputum negative or had 
extra-pulmonary TB and the fact that few patients had end 
TABLE 1: Demographic and clinical characteristics of the study population.
Variables Clinical characteristics
Crude analysis Stratified analysis 2008 Stratified analysis 2009 p-value
n % n % n %
Age: mean (s.d.)
Mean age of presentation 38.4 15.0 38.6 14.8 38.4 15.2 0.7
Sex
Male 569 57.3 271 53.3 285 61.8 0.008
Female 424 42.7 231 46.7 176 38.2
Mode of diagnosis
Smear microscopy only 370 37.3 110 21.7 239 51.8 0.000
Smear microscopy + Chest X-ray 346 34.8 282 55.5 62 13.4
Smear microscopy + Tissue biopsy 5 0.5 5 0.98 0 0
Chest X-ray only 251 25.3 109 21.5 142 30.8
Others (e.g. CSF analysis) 21 2.1 2 0.39 18 3.9
Mode of TB presentation
Smear positive PTB 332 33.4 147 - 169 36.7 0.000
Smear negative PTB 447 45.0 300 59.1 140 30.4
Extrapulmonary TB 214 21.6 61 12.0 152 32.9
Type of TB cases
New TB 873 87.9 44 87.6 409 88.7 0.002
Relapse TB 74 7.4 54 10.6 17 3.7
Transfer in 1 0.1 0 0 1 0.22 
Treatment after default 6 0.6 5 0.9 1 0.22
Treatment after failure 2 0.2 0 0 2 0.43
Others 36 3.7 4 0.8 31 0.43
Sputum conversion: % 51.3 - 48.8 - 53.1 - 0.078
TB treatment outcome 
Cure 253 25.4 101 19.9 138 29.9 0.004
Treatment completed 501 50.5 279 54.9 216 46.9
Treatment failure 1.0 6 1.2 4 0.87
Died 162 16.3 87 17.1 72 15.6
Treatment defaulted 7 0.7 3 0.6 4 0.8
Transferred out 60 6.0 32 6.3 27 5.9
TB and/or HIV collaborative activities
HIV testing uptake 760 76.7 353 69.5 388 84.5 0.000
TB and/or HIV co-infected 592 59.4 280 55.1 297 64.7
TB and/or HIV co-infected patients on ARVs 388 65.5 97 34.6 277 93.3
TB and/or HIV co-infected patients on co-trimoxazole 270 45.6 169 60.3 207 69.7
Mean CD4 counts 163.10 161.43 146.13 173.72 171.20 155.08 0.24
TB, tuberculosis.
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of treatment sputum examinations that would have allowed 
cure to be declared.
Most patients over the course of the study were started on 
treatment without initial sputum microscopy and the course 
of their illness was tracked by means of chest x-ray alone and 
they were thus recorded as treatment completed. The STOP 
TB target for treatment success is 85% consequently at 76% 
the SJHR success rate is well below this rate due largely to 
the fact that most SJHR patients were either smear negative 
or had extra-pulmonary TB.
The audit demonstrated a low cure rate, but relatively high 
treatment completion rate, which is largely due to the low 
numbers of patients that had sputum checked at the end of 
treatment. There was also a practice of advancing the patient 
to the maintenance phase based on radiological examination, 
after the initial intensive phase, but without confirmatory 
sputum conversion. This creates an ideal situation for 
multiple drug resistant (MDR) TB to go undetected. Data 
from previous MDR-TB studies done in Lesotho showed 
that DR-TB and MDR-TB were common amongst patients 
with treatment failure on the initial regimen. The proportion 
of MDR-TB was respectively 78% and 28% amongst the 
treatment failures and suspected failures. Early initiation 
of empiric second-line anti-tuberculosis treatment, whilst 
awaiting culture and drug susceptibility testing (DST) results, 
should be considered for HIV-negative and -positive patients 
who have failed first-line anti-tuberculosis treatment; and 
patients suspected to be failing a first-line regimen should 
undergo DST at the end of the intensive phase. Considering 
the alarmingly high incidence of MDR-TB in Lesotho, and in 
the neighbouring country of South Africa, the Lesotho NTP 
should be addressing this possibility. 10
The observed failure to follow up seems low for a country 
with a large number of migrant workers, taking into account 
a mortality rate of 16% and a transferred out rate of 6% 
reported in this clinical audit, although the low defaulter 
rate reported in this audit is in keeping with other previous 
studies in Lesotho. For example, a study on high risk of DR-
TB, when first-line therapy fails in a high HIV prevalence 
setting in Lesotho, showed that the default rate amongst 
the study population appeared to be quite low compared to 
typical default rates of 15% – 20% amongst MDR-TB patients 
in South Africa.10 Reasons for these low default rates were 
not entirely clear.
TB and/or HIV collaborative activities
HIV testing increased from 70% in 2007 to 85% in 2008. 
Antiretroviral (ARV) provision increased from 34% in 2007 
to 93% in 2008. Whilst cotrimoxazole uptake improved 
from 60% in 2007 to 67% in 2008 it still fell short of the 100% 
target. Attention to TB/HIV co-infection is fundamental to 
the lowering of TB/HIV mortality. In SSA 30% of TB and/
or HIV patients die within 12 months of treatment, largely 
from HIV-related infections. The improvements in the 
management of TB/HIV co-infected patients could explain 
the decrease in mortality from 2007 to 2008.
Conclusion
This study revealed weaknesses in baseline sputum evaluation, 
a low cure rate for new sputum smear positive patients, a 
low sputum conversion rate at 2 and 3 months in new smear 
positive patients, a high mortality in patients on TB treatment 
and a low cotrimoxazole uptake. These weaknesses showed 
how far SJHR has yet to go to meet NTP targets. However, it 
also revealed the following strengths: a low defaulter rate, an 
increase in HIV testing amongst TB patients and an improved 
ARV uptake in HIV co-infected TB patients.
The marginal improvements shown between 2007 and 2008 
probably reflect the fact that staff became more familiar 
with the requirements of the NTP and thus were able to 
combine the clinical and programmatic aspects of the NTP 
more closely.
This study constituted a worthwhile clinical audit with the 
benefits that usually accompany such exercises – the close 
attention to goals, targets, outcomes and the increase in staff 
familiarity with NTP protocols as well as the collection and 
analysis can only have increased their ability to implement 
TABLE 2: Comparison of targets achieved by St Joseph’s TB programme with the national target set by the Lesotho National Tuberculosis Programme.
Indicators National target set by  
the NTP of Lesotho  
(2007) 
(%)
Target achieved by  
St Joseph’s Hospital 
(2007)
(%)
Target met (2007)
Yes or No
Target achieved by  
St Joseph’s Hospital 
(2008)
(%)
Target met (2008)
Yes or No
Proportion of TB Cases who were smear positive 
detection
At least 70 28.9 No 36.7 No
Sputum conversion rate at 2 months > 85 48.8 No 53.1 No
Cure rate > 85 19.9 No 29.9 No
Treatment success rate > 85 74.8 No 76.5 No
Defaulter rate < 5 0.6 Yes 0.8 Yes
Mortality rate < 5 17.1 No 15.6 No
Treatment failure rate < 5 1.2 Yes 0.8 Yes
Proportion of TB patients offered HIV testing and 
counselling
100 69.5 No 84.5 No
Proportion of HIV positive TB patients started on 
cotrimoxazole
100 60.3 No 69.7 No
Proportion of HIV positive patients eligible for 
ARVs who are on HAART.
100 34.6 No 93.3 No
TB, tuberculosis.
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the Lesotho’s NTP to the benefit of TB patients. Further 
operational research should be conducted on the application 
of the NTP to help Lesotho move closer to the MDG goal 
of halving TB incidence and of achieving a cure rate of 
85% in all smear positive patients by 2015. This operational 
research should align itself with the priorities of the Stop 
TB Partnership’s Global Plan to Stop TB 2011–2015.This 
research should aim to develop interventions that will result 
in improved design and better performance of the health 
system with more efficient methods of service delivery. 
Suggested areas for priority research should include; access, 
screening and diagnosis of TB; access to and delivery 
of treatment for drug-susceptible and M/XDR-TB; and 
capacity-building of staff for operational research. 11
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